美国FDA药品数据库（U.S. FDA Drugs Database）
符合检索条件的记录共 17 条
共 1 页，当前第 1 页
| 商品名 |
申请号 |
产品号 |
申请类型 |
活性成分 |
剂型/给药途径 |
规格/剂量 |
RLD |
RS |
申请号原始批准/暂定批准日期 |
产品号批准日期 |
申请人 |
市场状态 |
| FULVESTRANT |
210044 |
001 |
ANDA |
FULVESTRANT |
SOLUTION;INTRAMUSCULAR |
250MG/5ML (50MG/ML) |
No
|
No
|
2019/03/04
|
2019/03/04
|
AMNEAL |
Prescription |
| FULVESTRANT |
205935 |
001 |
ANDA |
FULVESTRANT |
SOLUTION;INTRAMUSCULAR |
250MG/5ML (50MG/ML) |
No
|
No
|
2019/05/14
|
2019/05/14
|
SANDOZ |
Prescription |
| FULVESTRANT |
210326 |
001 |
NDA |
FULVESTRANT |
SOLUTION;INTRAMUSCULAR |
250MG/5ML (50MG/ML) |
No
|
No
|
2019/05/20
|
2019/05/20
|
FRESENIUS KABI USA |
Prescription |
| FULVESTRANT |
208811 |
001 |
ANDA |
FULVESTRANT |
SOLUTION;INTRAMUSCULAR |
250MG/5ML (50MG/ML) |
No
|
No
|
2019/07/23
|
2019/07/23
|
EUGIA PHARMA |
Prescription |
| FULVESTRANT |
210063 |
001 |
NDA |
FULVESTRANT |
SOLUTION;INTRAMUSCULAR |
250MG/5ML (50MG/ML) |
No
|
No
|
2019/08/19
|
2019/08/19
|
AVYXA HOLDINGS |
Discontinued |
| FULVESTRANT |
205871 |
001 |
ANDA |
FULVESTRANT |
SOLUTION;INTRAMUSCULAR |
250MG/5ML (50MG/ML) |
No
|
No
|
2019/08/22
|
2019/08/22
|
SAGENT PHARMS INC |
Prescription |
| FULVESTRANT |
207754 |
001 |
ANDA |
FULVESTRANT |
SOLUTION;INTRAMUSCULAR |
250MG/5ML (50MG/ML) |
No
|
No
|
2019/08/22
|
2019/08/22
|
GLENMARK PHARMS INC |
Prescription |
| FULVESTRANT |
209714 |
001 |
ANDA |
FULVESTRANT |
SOLUTION;INTRAMUSCULAR |
250MG/5ML (50MG/ML) |
No
|
No
|
2019/11/21
|
2019/11/21
|
HBT LABS INC |
Prescription |
| FULVESTRANT |
211422 |
001 |
ANDA |
FULVESTRANT |
SOLUTION;INTRAMUSCULAR |
250MG/5ML (50MG/ML) |
No
|
No
|
2020/02/07
|
2020/02/07
|
CHIA TAI TIANQING |
Prescription |
| FULVESTRANT |
209246 |
001 |
ANDA |
FULVESTRANT |
SOLUTION;INTRAMUSCULAR |
250MG/5ML (50MG/ML) |
No
|
No
|
2020/08/07
|
2020/08/07
|
DR REDDYS |
Prescription |
| FULVESTRANT |
211689 |
001 |
ANDA |
FULVESTRANT |
SOLUTION;INTRAMUSCULAR |
250MG/5ML (50MG/ML) |
No
|
No
|
2020/11/17
|
2020/11/17
|
ACCORD HLTHCARE |
Prescription |
| FULVESTRANT |
211730 |
001 |
ANDA |
FULVESTRANT |
SOLUTION;INTRAMUSCULAR |
250MG/5ML (50MG/ML) |
No
|
No
|
2021/06/11
|
2021/06/11
|
APOTEX |
Discontinued |
| FULVESTRANT |
215234 |
001 |
ANDA |
FULVESTRANT |
SOLUTION;INTRAMUSCULAR |
250MG/5ML (50MG/ML) |
No
|
No
|
2021/07/29
|
2021/07/29
|
ZYDUS PHARMS |
Prescription |
| FULVESTRANT |
213553 |
001 |
ANDA |
FULVESTRANT |
SOLUTION;INTRAMUSCULAR |
250MG/5ML (50MG/ML) |
No
|
No
|
2021/08/13
|
2021/08/13
|
XIROMED |
Prescription |
| FULVESTRANT |
214682 |
001 |
ANDA |
FULVESTRANT |
SOLUTION;INTRAMUSCULAR |
250MG/5ML (50MG/ML) |
No
|
No
|
2022/02/10
|
2022/02/10
|
JIANGSU HANSOH PHARM |
Prescription |
| FULVESTRANT |
215077 |
001 |
ANDA |
FULVESTRANT |
SOLUTION;INTRAMUSCULAR |
250MG/5ML (50MG/ML) |
No
|
No
|
2022/12/22
|
2022/12/22
|
ALEMBIC |
Prescription |
| FULVESTRANT |
215169 |
001 |
ANDA |
FULVESTRANT |
SOLUTION;INTRAMUSCULAR |
250MG/5ML (50MG/ML) |
No
|
No
|
2023/06/30
|
2023/06/30
|
EUGIA PHARMA |
Prescription |